Henry Schein (NASDAQ:HSIC) Shares Break Above Two Hundred Day Moving Average - Here's Why

Key Points

• Henry Schein shares broke above their 200-day moving average, reaching $85.51 before closing at $84.23, compared with the average of $81.51.
• Analyst sentiment has improved, with several firms raising price targets; the stock carries a “Moderate Buy” consensus rating and a consensus target of $92.93.
• The company exceeded quarterly expectations, reporting $1.27 in earnings per share and $3.46 billion in revenue, while year-over-year revenue increased 6.7%.

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $81.51 and traded as high as $85.51. Henry Schein shares last traded at $84.23, with a volume of 1,904,336 shares traded.

Analysts Set New Price Targets

A number of research firms have recently weighed in on HSIC. Wall Street Zen upgraded shares of Henry Schein from a "hold" rating to a "buy" rating in a research note on Monday, August 17th. Weiss Ratings upgraded Henry Schein from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Friday, August 21st. Barclays reissued an "overweight" rating and set a $100.00 target price (up from $86.00) on shares of Henry Schein in a research note on Thursday, August 6th. BMO Capital Markets assumed coverage on Henry Schein in a research note on Wednesday, July 8th. They issued a "market perform" rating and a $85.00 price target on the stock. Finally, BTIG Research increased their price target on Henry Schein from $100.00 to $110.00 and gave the stock a "buy" rating in a report on Wednesday, August 19th. Nine research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $92.93.

Henry Schein Stock Down 0.8%

The stock has a 50-day moving average of $87.79 and a 200 day moving average of $81.51. The company has a market capitalization of $9.39 billion, a PE ratio of 24.56, a P/E/G ratio of 1.50 and a beta of 0.84. The company has a quick ratio of 0.73, a current ratio of 1.32 and a debt-to-equity ratio of 0.60.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.27 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.03. The business had revenue of $3.46 billion for the quarter, compared to analysts' expectations of $3.37 billion. Henry Schein had a return on equity of 15.97% and a net margin of 2.96%.The business's revenue was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.10 earnings per share. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. Sell-side analysts anticipate that Henry Schein, Inc. will post 5.36 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Operose Advisors LLC bought a new stake in shares of Henry Schein in the 2nd quarter worth approximately $33,000. Trust Co. of Vermont purchased a new position in Henry Schein in the second quarter valued at approximately $42,000. Versant Capital Management Inc grew its holdings in Henry Schein by 175.4% during the second quarter. Versant Capital Management Inc now owns 617 shares of the company's stock valued at $52,000 after purchasing an additional 393 shares during the period. EverSource Wealth Advisors LLC grew its holdings in Henry Schein by 167.4% during the first quarter. EverSource Wealth Advisors LLC now owns 936 shares of the company's stock valued at $69,000 after purchasing an additional 586 shares during the period. Finally, Contravisory Investment Management Inc. purchased a new stake in Henry Schein in the second quarter worth $84,000. 96.62% of the stock is owned by institutional investors.

About Henry Schein

Henry Schein, Inc NASDAQ: HSIC is a global provider of health care products and services serving dental and medical professionals, laboratories, health care institutions and veterinary practices. The company operates primarily as a distributor, helping customers obtain medical, dental and veterinary supplies, equipment, pharmaceuticals and related products.

In addition to product distribution, Henry Schein provides technology solutions and value-added services designed to support practice management, clinical workflows, procurement, compliance and business operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.